Leaderboards/Peripheral Artery Disease Management

Peripheral Artery Disease Management

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Iris H. Liu
University of California, San Francisco
2
Jinfeng Lin
Fuzhou University
3
Benjamin Nilsson Wadström
University of Copenhagen
4
Jing‐Wei Gao
Sun Yat-sen University
5
Takuya Haraguchi
Sapporo Science Center
6
Lena Makowski
University Hospital Münster
7
John S M Houghton
University Hospitals of Leicester NHS Trust
8
Anna G. Hoek
GGD Amsterdam
9
Sanuja Bose
University of Baltimore
10
Daniel Messiha
West German Heart and Vascular Center Essen

Rising Stars Papers

1
Multiscale reconfiguration induced highly saturated poling in lead-free piezoceramics for giant energy conversion
Nature Communications|2024
50 cit.
2
New Horizons in Peripheral Artery Disease
Age and Ageing|2024
30 cit.
3
Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study
Arteriosclerosis Thrombosis and Vascular Biology|2024
29 cit.
4
Elevated Remnant and LDL Cholesterol and the Risk of Peripheral Artery Disease
Journal of the American College of Cardiology|2025
14 cit.
5
Tailoring the microstructure of lead-free KNN piezoelectric ceramics for force-sensitive smart windows
Microstructures|2025
11 cit.
6
Editor's Choice – Infrapopliteal Peripheral Vascular Interventions for Claudication are Performed Frequently in the USA and Are Associated with Poor Long Term Outcomes
European Journal of Vascular and Endovascular Surgery|2024
10 cit.
7
Small Remnants versus Large Triglyceride-Rich Lipoproteins in Risk of Atherosclerotic Cardiovascular Disease
Clinical Chemistry|2025
9 cit.
8
Infrapopliteal Endovascular Interventions for Claudication Are Associated With Poor Long-term Outcomes in Medicare-matched Registry Patients
Annals of Surgery|2024
7 cit.
9
Streamlined Clinical Management Pathways May Reduce Major Amputations in Patients with Chronic Limb Threatening Ischaemia: A Prospective Cohort Study with Historical Controls
European Journal of Vascular and Endovascular Surgery|2024
6 cit.
10
Validation of <i>ICD-10</i> Codes to Distinguish Between Claudication and Chronic Limb-Threatening Ischemia in Patients Undergoing Peripheral Vascular Intervention Using Medicare-Matched Registry Data
Circulation Cardiovascular Quality and Outcomes|2025
6 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Agu Obiekezie
Unknown
2
Ramón Roca‐Tey
Institut de Seguretat Pública de Catalunya
3
Joakim Nordanstig
Sahlgrenska University Hospital
4
Kumud Rai
Max Healthcare
5
Tim Shephard
University of Sheffield
6
Prashanth Vas
King's College London
7
Chris Manu
King's College London
8
Chiara Summaria
University of Calabria
9
Renato Rapanà
ASL Roma
10
Eric A. Secemsky
Beth Israel Deaconess Medical Center

Emerging Leaders Papers

1
Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication
European Journal of Vascular and Endovascular Surgery|2023
423 cit.
2
Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA
European Heart Journal|2023
57 cit.
3
Appropriate Use of Intravascular Ultrasound During Arterial and Venous Lower Extremity Interventions
JACC: Cardiovascular Interventions|2022
55 cit.
4
Temporal Trends, Practice Variation, and Associated Outcomes With IVUS Use During Peripheral Arterial Intervention
JACC: Cardiovascular Interventions|2022
51 cit.
5
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial
The Lancet|2025
43 cit.
6
Differences in Comorbidities Explain Black–White Disparities in Outcomes After Femoropopliteal Endovascular Intervention
Circulation|2022
38 cit.
7
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial
The Lancet|2025
30 cit.
8
Incidence, Treatment, and Outcomes of Symptomatic Device Lead-Related Venous Obstruction
Journal of the American College of Cardiology|2023
25 cit.
9
Postmarketing Surveillance of Inferior Vena Cava Filters Among US Medicare Beneficiaries
JAMA|2024
25 cit.
10
Impact of Intensity of Vascular Care Preceding Major Amputation Among Patients With Chronic Limb-Threatening Ischemia
Circulation Cardiovascular Interventions|2023
24 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Thomas Zeller
Universitäts-Herzzentrum Freiburg-Bad Krozingen
2
Michael H. Criqui
University of California San Diego
3
Kathryn A. Taubert
Southwestern Medical Center
4
Victor Aboyans
The Princess Grace Hospital
5
Jean‐Baptiste Ricco
Primary Health Care
6
Alan T. Hirsch
University of Minnesota Medical Center
7
Michael S. Conte
University of California San Francisco Medical Center
8
Dierk Scheinert
University Hospital Leipzig
9
Michael R. Jaff
Boston Scientific (United States)
10
Mary Mcdermott
Northwestern University

Current Senior Leaders Papers

1
Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
JAMA|2001
2.8k cit.
2
Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease
New England Journal of Medicine|1992
2.6k cit.
3
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
Circulation|2011
2.2k cit.
4
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
Circulation|2006
2.1k cit.
5
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
Circulation|2004
1.9k cit.
6
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
Circulation|2011
1.8k cit.
7
Infective Endocarditis
Circulation|2005
1.7k cit.
8
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
European Journal of Vascular and Endovascular Surgery|2019
1.5k cit.
9
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
PEDIATRICS|2004
1.4k cit.
10
The prevalence of peripheral arterial disease in a defined population.
Circulation|1985
1.1k cit.

Reagents for Peripheral Artery Disease Management

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

Vimentin (D21H3) Rabbit Monoclonal Antibody (APC Conjugate)

#95159$465
View Evidence →
Cell Signaling TechnologyEvidence 65

Cleaved PARP (Asp214) (D64E10) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Violet 510 Conjugate)

#53137$486
View Evidence →
Cell Signaling TechnologyEvidence 67

Phospho-PLCbeta3 (Ser537) Antibody

#2481$362
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

Phospho-PLC gamma1 (Ser1248) (D25A9) Rabbit Monoclonal Antibody (BSA and Azide Free)

#16685$898
View Evidence →
Cell Signaling TechnologyEvidence 65

HTRA1/PRSS11 (F5F1P) Rabbit Monoclonal Antibody (BSA and Azide Free)

#55142$865
View Evidence →
Cell Signaling TechnologyEvidence 66

PKC-delta Antibody

#2058$317
View Evidence →